TuHURA Biosciences Inc HURA.OQ HURA.O is expected to report resultson February 12 (estimated) for the period ending December 31 2024
LSEG's mean analyst estimate for TuHURA Biosciences Inc is for a loss of 13 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for TuHURA Biosciences Inc is $12.13, above its last closing price of $4.27.
This summary was machine generated February 10 at 11:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)